Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jayaram-Lindstrom N et al. - Overall, 55 patients (68.8%) completed the trial. The intention-to-treat analysis showed that the naltrexone group had a significantly higher number of amphetamine-negative urine samples compared with the placebo group. Survival analyses showed that the treatment groups differed in rate of continuous abstinence, in both the intention-to-treat and completer samples, in favor of naltrexone treatment. There was a significant reduction in craving levels and self-reported consumption of amphetamine in the naltrexone group compared with the placebo group. Treatment with naltrexone was well tolerated in this sample.

Related Articles

Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study
Drug and Alcohol Dependence, 10/26/09    Relevance Score: 96%

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis
BMC Cancer, 10/21/09    Relevance Score: 96%

Acamprosate and Prevention of Relapse in Alcoholics
European Addiction Research, 11/16/09    Relevance Score: 94%

Effects of Treatment for Tobacco Dependence on Resting Cerebral Glucose Metabolism
Neuropsychopharmacology, 10/29/09    Relevance Score: 94%

A randomized trial of contingency management for adolescent marijuana abuse and dependence
Drug and Alcohol Dependence, 10/26/09    Relevance Score: 94%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address